REViV is a minimally manipulated human tissue allograft derived from the amniotic fluid and the extracellular matrix of the amniotic membrane. REViV is for homologous use and is intended to regulate and maintain tissue regenerative processes.
The extracellular matrix of REViV contains a high concentration of cellular scaffolding, cytokines, growth factors, and proteins. The extracellular matrix(ECM) is a collection of extracellular molecules that provide the structural support needed for surrounding cells. Amniotic ECM is comprised of collagens, multi-adhesive glycoproteins, elastic, glycosaminoglycans, growth factors, and cytokines.
Potential Treatment Areas:
REViV™ is processed from donated amniotic fluid and membrane from full-term deliveries. All donors are pre-screened and undergo comprehensive testing that includes: